Free Trial

Castle Biosciences (CSTL) SEC Filings & 10K Form

Castle Biosciences logo
$25.75 -0.40 (-1.53%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$25.74 0.00 (-0.02%)
As of 02/21/2025 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Castle Biosciences SEC Filings

DateFilerForm TypeView
02/05/2025
3:25 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2025
8:33 PM
Castle Biosciences (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/15/2025
3:57 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
5:58 AM
Castle Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
5:19 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
5:17 PM
Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
5:18 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
3:39 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:21 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
4:00 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
3:55 PM
Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
4:09 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:28 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:14 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
5:21 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
5:44 PM
Castle Biosciences (Subject)
WASATCH ADVISORS LP (Filed by)
Form SC 13G/A
11/06/2024
3:21 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:32 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:33 PM
Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
4:34 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2024
3:49 PM
Castle Biosciences (Subject)
Juvenal Tobin W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/16/2024
3:34 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2024
3:22 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
3:30 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
3:48 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
4:33 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:23 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:33 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:15 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
4:18 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2024
3:06 PM
Castle Biosciences (Issuer)
Oelschlager Kristen M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:07 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
3:11 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
4:17 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
5:13 PM
Castle Biosciences (Issuer)
Stokes Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
5:14 PM
Castle Biosciences (Issuer)
Stokes Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
5:15 PM
Castle Biosciences (Issuer)
Oelschlager Kristen M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
5:16 PM
Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
5:17 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:37 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/02/2024
2:13 PM
Castle Biosciences (Subject)
Stokes Frank (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Collect $7k per month from Tesla’s SECRET dividend (Ad)

There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?

Click here to uncover Tesla's hidden income secret.
07/16/2024
5:43 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4/A
07/16/2024
3:49 PM
Castle Biosciences (Issuer)
Goldberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
3:51 PM
Caple Kim (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
3:32 PM
BlackRock Inc. (Filed by)
Castle Biosciences (Subject)
Form SC 13G/A
07/01/2024
3:45 PM
Castle Biosciences (Subject)
Oelschlager Kristen M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2024
4:23 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:52 PM
Aspinall Mara G. (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
4:21 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2024
3:40 PM
Castle Biosciences (Issuer)
Harrison Miles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
3:41 PM
Castle Biosciences (Issuer)
Goldberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
3:43 PM
Castle Biosciences (Issuer)
Cole G Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
3:44 PM
Caple Kim (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
3:46 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
3:37 PM
Castle Biosciences (Issuer)
Olson Tiffany (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:18 PM
Castle Biosciences (Issuer)
Cotton Rodney (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:10 PM
Castle Biosciences (Issuer)
Olson Tiffany (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:13 PM
Castle Biosciences (Issuer)
Goldberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:15 PM
Caple Kim (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:05 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:06 PM
Castle Biosciences (Issuer)
Cole G Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:08 PM
Castle Biosciences (Issuer)
Harrison Miles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
2:14 PM
Castle Biosciences (Filer)
Form DEFA14A
05/08/2024
3:47 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
3:51 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:15 PM
Castle Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2024
3:54 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
11:15 PM
Castle Biosciences (Filer)
Form EFFECT
04/16/2024
3:46 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
3:36 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2024
3:35 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:05 PM
Castle Biosciences (Filer)
Form DEF 14A
04/10/2024
3:07 PM
Castle Biosciences (Filer)
Form DEFA14A
04/10/2024
3:08 PM
Castle Biosciences (Filer)
Form ARS
04/08/2024
3:31 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2024
3:37 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
4:02 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/28/2024
3:43 PM
Castle Biosciences (Issuer)
Cotton Rodney (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:30 PM
Castle Biosciences (Issuer)
Cotton Rodney (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/22/2024
4:16 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
4:18 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
4:14 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
4:58 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:00 PM
Castle Biosciences (Issuer)
Stokes Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:04 PM
Castle Biosciences (Issuer)
Oelschlager Kristen M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:07 PM
Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:52 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:14 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
4:08 PM
Castle Biosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/28/2024
4:15 PM
Castle Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CSTL) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners